2.05 (-%)
As of Oct 31, 2024
Source:
Alaunos Therapeutics, Inc is a clinical-stage oncology-focused cell therapy company developing adoptive TCR-T cell therapy, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs.
Country | United States |
Headquarters | houston, texas |
Phone Number | (346) 355-4099 |
Industry | manufacturing |
CEO | Kevin S. Boyle, Sr. |
Website | www.alaunos.com |